AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
70.76
-0.48 (-0.67%)
At close: Jan 31, 2025, 4:00 PM
70.08
-0.68 (-0.96%)
After-hours: Jan 31, 2025, 6:11 PM EST
AstraZeneca Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AstraZeneca stock have an average target of 89.75, with a low estimate of 82 and a high estimate of 97. The average target predicts an increase of 26.84% from the current stock price of 70.76.
Analyst Consensus: Buy
* Price targets were last updated on Aug 12, 2024.
Analyst Ratings
The average analyst rating for AstraZeneca stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 3 | 3 | 3 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 10 | 10 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Nov 20, 2024 |
| Erste Group | Erste Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 11, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $90 → $95 | Strong Buy | Maintains | $90 → $95 | +34.26% | Aug 12, 2024 |
| Argus Research | Argus Research | Strong Buy Maintains $80 → $85 | Strong Buy | Maintains | $80 → $85 | +20.12% | May 30, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $97 | Strong Buy | Initiates | $97 | +37.08% | May 30, 2024 |
Financial Forecast
Revenue This Year
54.61B
from 45.81B
Increased by 19.21%
Revenue Next Year
58.41B
from 54.61B
Increased by 6.95%
EPS This Year
4.19
from 3.81
Increased by 10.06%
EPS Next Year
4.77
from 4.19
Increased by 13.65%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 56.5B | 62.6B | 69.1B | |||
| Avg | 54.6B | 58.4B | 61.8B | |||
| Low | 49.8B | 51.9B | 55.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 23.4% | 14.6% | 18.4% | |||
| Avg | 19.2% | 7.0% | 5.8% | |||
| Low | 8.6% | -5.0% | -5.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 4.49 | 5.54 | 6.38 | |||
| Avg | 4.19 | 4.77 | 5.33 | |||
| Low | 3.47 | 3.91 | 4.35 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 17.8% | 32.2% | 34.0% | |||
| Avg | 10.1% | 13.7% | 11.8% | |||
| Low | -9.0% | -6.9% | -8.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.